Can BioMarin Stock Live Up to Wall Street's High Expectations?

BioMarin Pharmaceutical TodayBMRNBioMarin Pharmaceutical$63.44 +0.88 (+1.41$61.15▼$99.56P/E Ratio37.99Price Target$94.20Add to WatchlistBioMarin Pharmaceutical NASDAQ: BMRN has been a rough investment for a long time. Over the past 10 years, shares have provided a total return of -28%. However, Wall Street analysts have consistently given this stock price targets that are much higher than its trading price. They see more fundamental value in the company than the market will give it credit f ...